Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport in Chronic Plantar Fasciitis
NCT00447876Phase 3Completed
- Sponsor
- Ipsen
- Start
- Jul 2005
- Primary completion
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of abobotulinumtoxinA in plantar fasciitis, sponsored by Ipsen. Started Jul 2005; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on NCT00447876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447876.